Author:
Liu Juan,Qin Cheng-Kun,Lv Wei,Zhao Qi,Qin Cheng-Yong
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference49 articles.
1. Global cancer statistics, 2002.;Parkin;CA Cancer J Clin,2005
2. .Annual report to the nation on the status of cancer, 1975-2002 featuring population-based trends in cancer treatment.;Edwards;J Natl Cancer Inst,2005
3. A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism.;Johnson;Blood,2005
4. OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells.;Yacoub;Mol Pharmacol,2006
5. OSU-03012 in the treatment of glioblastoma.;McCubrey;Mol Pharmacol,2006
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献